Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Waverley Pharma Inc
V.WAVE
Healthcare
Biotechnology
Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution...
agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:WAVE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(5)
•••
tankingfrank
X
View Profile
View Bullboard History
Comment by
tankingfrank
on Aug 04, 2020 1:11pm
RE:Wave pharma has cancer drug approved in UE
its a two dollar stock.. these sellers just dont know it yet.. lol.
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Aug 04, 2020 12:47pm
Wave pharma has cancer drug approved in UE
FDA should follow soon
(5)
•••
tankingfrank
X
View Profile
View Bullboard History
Post by
tankingfrank
on Aug 04, 2020 12:35pm
will be a nice winner
when the next news comes around --- 12 million mkt cap .
(1)
•••
nomoney
X
View Profile
View Bullboard History
Comment by
nomoney
on Aug 04, 2020 10:29am
RE:Scotia has the worst platform to do online banking
Just looked on Down detector and apparently I'm not the only one having this issue. Total B.S.
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Comment by
moneywinner1
on Aug 04, 2020 10:23am
RE:Scotia has the worst platform to do online banking
They hardly speak English when I called them
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Aug 04, 2020 10:22am
Scotia has the worst platform to do online banking
Garbage
(1)
•••
nomoney
X
View Profile
View Bullboard History
Post by
nomoney
on Aug 04, 2020 10:20am
OT
Anyone else trade through Scotia iTrade? Is your account down by any chance? Mine is down for the second time in as many weeks. TIA
(5)
•••
tankingfrank
X
View Profile
View Bullboard History
Comment by
tankingfrank
on Aug 04, 2020 9:46am
RE:RE:RE:MCap $13 M /Profitability& 2 BIG Cancer drug approvals in Q4
they got a lot going. most of the float is probably already held tight. some big news on FDA or covid and i am fairly confident this stock will be a lot higher. people will be chasing, so you
...more
(65)
•••
Kusanation
X
View Profile
View Bullboard History
Comment by
Kusanation
on Aug 04, 2020 9:05am
RE:MCap $13 M /Profitability& 2 BIG Cancer drug approvals in Q4
When is FDA approval expected ?
(65)
•••
Kusanation
X
View Profile
View Bullboard History
Post by
Kusanation
on Aug 04, 2020 8:21am
ATE is a massive proven opportunity!
For anyone interested in Biotech. Check out ATae and their latest report released today of their blockbuster drug and extensive success in phase 2B. Hugely undervalued stock, get it while you can
...more
(186)
•••
Vic1234
X
View Profile
View Bullboard History
Comment by
Vic1234
on Aug 02, 2020 9:52pm
RE:RE:RE:RE:$1M in cash. No PP is needed. 13M free float.
It looks like this stock is too undervalued based on details provided above.
(131)
•••
AGResearch
X
View Profile
View Bullboard History
Comment by
AGResearch
on Aug 02, 2020 12:52pm
RE:RE:RE:$1M in cash. No PP is needed. 13M free float.
Couple of important pieces of DD that you've missed: Waverley Pharma Announces Collaboration with Dr. David E. Herbert and the University of Manitoba for the Development of a Synthetic Library of
...more
(18)
•••
Investor62
X
View Profile
View Bullboard History
Comment by
Investor62
on Aug 02, 2020 6:20am
RE:RE:$1M in cash. No PP is needed. 13M free float.
I have done my personal DD for WAVE and from a financial position it looks promising. (sorry when some are not interested in all the figures but I think worth to see them). There are some open
...more
(3)
•••
Eizenberg
X
View Profile
View Bullboard History
Comment by
Eizenberg
on Aug 01, 2020 7:38pm
RE:$1M in cash. No PP is needed. 13M free float.
13M float, it will be a very wild ride ! The SP had the "chance" to be dumped but it bottomed at 0,215 and close higher. The next days to come look very promising.
(131)
•••
AGResearch
X
View Profile
View Bullboard History
Post by
AGResearch
on Aug 01, 2020 1:51pm
$1M in cash. No PP is needed. 13M free float.
They have an existing revenue stream and have not had any capital raises since 2017 IPO at .50. No cheap paper to hold it down. $340K revs in Q1 2020 (up 40% over 2019) and only $83K away from
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden